D

Disc Medicine

50 employees

Disc Medicine is a biopharmaceutical company that develops therapies for hematologic diseases and rare blood disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical
Pharmaceutical

Date founded

2017

Funding rounds raised

Total raised

$90M

from 13 investors over 13 rounds

D

Disc Medicine raised $64M on February 4, 2023

Investors: OrbiMed Advisors

D

Disc Medicine raised $54M on August 10, 2022

Investors: OrbiMed Advisors, Atlas Venture, Novo Holdings, 5AM Ventures and Arix Bioscience plc

D

Disc Medicine raised $90M on September 2, 2021

Investors: Willett Advisors LLC, Atlas Venture, Arix Bioscience plc, OrbiMed Advisors and Novo Holdings

D

Disc Medicine raised $50M on October 30, 2019

Investors: Novo Holdings and Atlas Venture

FAQ